Pulse Biosciences, Inc.
PLSE
$21.11
$0.180.84%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 80.74M | 95.21M | 106.35M | 119.28M | 118.04M |
| Total Receivables | 274.00K | 15.00K | -- | -- | -- |
| Inventory | 136.00K | 57.00K | 51.00K | 30.00K | -- |
| Prepaid Expenses | 2.28M | 1.87M | 1.76M | 1.60M | 1.41M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 83.42M | 97.16M | 108.16M | 120.91M | 119.45M |
|
|
|||||
| Total Current Assets | 83.42M | 97.16M | 108.16M | 120.91M | 119.45M |
| Net Property, Plant & Equipment | 7.06M | 7.37M | 7.72M | 7.95M | 8.32M |
| Long-term Investments | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Goodwill | 2.79M | 2.79M | 2.79M | 2.79M | 2.79M |
| Total Other Intangibles | 575.00K | 741.00K | 907.00K | 1.05M | 1.22M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 691.00K | 705.00K | 677.00K | 678.00K | 677.00K |
| Total Assets | 94.54M | 108.77M | 120.25M | 133.38M | 132.46M |
|
|
|||||
| Total Accounts Payable | 2.78M | 2.98M | 2.74M | 2.37M | 1.67M |
| Total Accrued Expenses | 3.58M | 5.20M | 4.78M | 3.98M | 5.83M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.57M | 1.52M | 1.46M | 1.41M | 1.36M |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | 1.20M |
| Total Other Current Liabilities | -- | -- | -- | -- | 1.20M |
| Total Current Liabilities | 7.92M | 9.70M | 8.98M | 7.76M | 10.06M |
|
|
|||||
| Total Current Liabilities | 7.92M | 9.70M | 8.98M | 7.76M | 10.06M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 5.96M | 6.37M | 6.79M | 7.17M | 7.54M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 13.88M | 16.07M | 15.76M | 14.93M | 17.60M |
|
|
|||||
| Common Stock & APIC | 543.94M | 538.54M | 530.95M | 525.75M | 505.36M |
| Retained Earnings | -463.28M | -445.85M | -426.46M | -407.30M | -390.50M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 80.66M | 92.69M | 104.49M | 118.45M | 114.86M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 80.66M | 92.69M | 104.49M | 118.45M | 114.86M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 80.66M | 92.69M | 104.49M | 118.45M | 114.86M |
|
|
|||||